Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1992 2
1996 3
1997 5
1998 5
1999 6
2000 15
2001 8
2002 13
2003 16
2004 29
2005 27
2006 22
2007 22
2008 23
2009 18
2010 32
2011 34
2012 34
2013 24
2014 29
2015 35
2016 28
2017 27
2018 11
2019 14
2020 15
2021 10
2022 6
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 19730353

470 results

Results by year

Filters applied: . Clear all
Page 1
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial.
Llombart-Cussac A, Ruiz A, Antón A, Barnadas A, Antolín S, Alés-Martínez JE, Alvarez I, Andrés R, García Saenz JA, Lao J, Carrasco E, Cámara C, Casas I, Martín M. Llombart-Cussac A, et al. Cancer. 2012 Jan 1;118(1):241-7. doi: 10.1002/cncr.26299. Epub 2011 Jun 29. Cancer. 2012. PMID: 21717449 Free article. Clinical Trial.
Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on letrozole or anastrozole. A phase II trial conducted by the Hellenic Group of Oncology (HELGO).
Gennatas C, Michalaki V, Carvounis E, Psychogios J, Poulakaki N, Katsiamis G, Voros D, Kouloulias V, Mouratidou D, Tsavaris N. Gennatas C, et al. Tumori. 2006 Jan-Feb;92(1):13-7. doi: 10.1177/030089160609200103. Tumori. 2006. PMID: 16683378 Clinical Trial.
Clinical evaluation of the use of exemestane as further hormonal therapy after nonsteroidal aromatase inhibitors in postmenopausal metastatic breast cancer patients.
Carlini P, Michelotti A, Ferretti G, Ricci S, Giannarelli D, Pellegrini M, Cresti N, Di Cosimo S, Bria E, Papaldo P, Fabi A, Ruggeri EM, Milella M, Alimonti A, Salesi N, Cognetti F. Carlini P, et al. Cancer Invest. 2007 Mar;25(2):102-5. doi: 10.1080/07357900701224789. Cancer Invest. 2007. PMID: 17453821
470 results